Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitors - Reinbold, R; Hvinden, IC; Rabe, P; Herold, RA; Finch, A; Wood, J; Morgan, M; Staudt, M; Clifton, IJ; Armstrong, FA; McCullagh, JSO; Redmond, J; et al. (Nature Communications, 2022)